# Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand

> **Open Intelligence Dossier** · First detected: 2026-10-29 11:20 UTC · Category: Business

## Executive Summary
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand&quot; is generating significant coverage in the Business category, with 8 articles from 8 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Yahoo Finance, WSJ, Eli Lilly and Barchart.com. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo Finance | Eli Lilly (NYSE:LLY) reports upbeat Q3 2026, guides for strong full-year sales | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxPazBla1NLU1FBbVhoT3Y0bWdKeFl1a0dmSTZsY0VZLVNjTHJWWjJCdTBEaXV1SmdlczhORHpId1k2X2ZINGVSd0hnZ25iY05teHhzM0hFNXhtbzJrVDRHMjRzRW92dGxMSWIyd0dxUWVQUDJud1loY2xEVzNsWU9jU0ZLNnVGTW12MEVCZFQ3eEM?oc=5) |
| WSJ | Eli Lilly Revenue Climbs on Demand for Mounjaro, Zepbound | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxOclRtZU5JQmczMHIwRDJIVUFyYkE0VjZCX1pXb2ZiV2hBbnp2WjYxN0d1T194NEVxZ0xMbEd5REt4TTVaZG5jTlhYc21CTUNkc2JfZ0FzQjFZcHBHa0RfZU9wZHlEYWQwWmlCaXU4QlZ6dC16VkRrNXF0RTlqeDRzMUNfTFBtOVRiTFdSWW9zc3hoLVpXRkpNRlVpNEx4bUZi?oc=5) |
| Eli Lilly | Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio | [Source Link](https://news.google.com/rss/articles/CBMiwgFBVV95cUxPUlZheEJNa1ZUZWU4Smh4clVqdTlzUDAzbFZ4TmVVRkFlVmtLa084WGlnTjFkNjZEOFBYcnB4NVp5VWpxNldUT04tS0lnS3Jpc1NVczkwTmthdDJfdDR5Nk1LZmg5YlpJRmItQ3ZTRkRxLUk2VDVCUm5zd3J2c3dYOFEwUnJJVC11YkY1aFJHT0NzaDBrNDRaZHM3cEhteVBuRWlwQ0g5VU5iLVYxcUdULU1RbnlESm5oal9MRkVXc0hjUQ?oc=5) |
| Barchart.com | Ahead of Eli Lilly Earnings, Here's What Barchart Data Says Comes Next for LLY Stock | [Source Link](https://news.google.com/rss/articles/CBMixgFBVV95cUxQSmMxQXpGSkZfZTlBQngxUjJSMDc0ZDB0Zm13eEJIU0VxSVJTWmVHSEs1V0FEbXluak55UnljVlJiWklrX3FOb0xMUVFDU1BqQTlEeGVRVmJaM3poeGxFYTk2YnYwNlFxMGlBV1pycHREVVRxRHVTMzA3UE5ZVDI5OTFNV0dKejZXOTFWUERhaDVHU25FSTF6c3ZTTzZaVDQyWTViV0R2MkhtZGlBVjROSkozSmlLQnBDZTh5cE9OcHRmVVUtOHc?oc=5) |
| Barron's | Eli Lilly Stock Jumps as Monster Earnings Powered by Mounjaro and Zepbound | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxQa21oUTZHaDNOcF8xc2pSeDVIdzNtWkRCWWhaSzZkNk9jVEQwU1k3a2FaSHJjRFlPVkZUZDhaeFlaZGRLQ19rYVVNVHZqcVVlemRwYnNQZTlfLU9FV3NvWU51MHd1RUJjVDRsc2ZGb0dWZlBKaHJNWVRUampUdkU2Mkdja2c4aVk3UFNSbjhTVVVGTWhY?oc=5) |
| Reuters | Eli Lilly lifts revenue outlook on weight-loss drug sales, trims profit view on deal charges | [Source Link](https://news.google.com/rss/articles/CBMi4wFBVV95cUxOOFBMR0czdDM3ak5TQVJZYmZ5cENsNkZQaGRSRlFocDQ4dThYVmUyTFV6Z0x5VXVyX3BRTmF3R1lta0lRVGdSN0NDWmJMZzUwRUIwTnN4RFlpLVNhQi1oZVl0WER0M3NOcnFQR0FQa3hBck0yY1Y0T0dkOS1wZm1iaUQ4YjNsZzY0NzFoU0w2cGh3bmQzekRUanFTa29GdDF6RFdYQ3lqV200Y1NiaENLQWdFUEVValozTzMwYjFWS1UyTExLV01NZkxjQm9EcWFDNUNEYWk4XzhDekxCU0R4M0pjYw?oc=5) |
| Bloomberg | Lilly Raises Sales Guidance, Widening Its Lead in Obesity Market | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxPZTJnbHFxeWYyclE0Y2VnLUhseGNhYVVRMi1HcXA3YnotWWM3dWgzRVZGa2FDLS03TlJITGRoWUJoNVBCVHptcXpRQWxEa2xQSWVGSzZSeklYVS1kOURlMzY2b1dhN3d4UF9WWEdvQWhfMGRNdmxEaldqOW0zd3ZCM1IzaHhLRWZTT2VzSmlwUWVnNmNIMWlhMUZvQjdlOVBCa2kybkRwWTFNTXJGbzZPZWNNb0E?oc=5) |
| CNBC | Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand | [Source Link](https://news.google.com/rss/articles/CBMidkFVX3lxTE9NdFQ3UUxsNVQtQmtLandjang0Nk5QZ2xEb3B1TU11X2dYVUdVSUFNaTdLOGhCR3VTUVdlT19WY0VkVE1FMm9uUzhIckpsT1BmM1RVbUw1ZWJZVTJ3MVdxREZlVVlPRXZjTjMzTXoxWXhMaVpEQUHSAXtBVV95cUxOOU9NT0xZb0dQZ3g4a19zaThfLWltR1N6OFJzQjVxOXVNeDRZWnhNQnRqWHMybTZDODQ1b3pPVXRRT18zYVZBUHBiN3dUN1RYQXoyQ3AtWkZkXzRWSWl1NVppWFR0YndnNF9sNXJxdzlHdVVlLWlfclBJRkU?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-10-29/eli-lilly-blows-past-estimates-hikes-sales-outlook-on-resilient-zepbound-and*
